Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-2006 | 04-2005 | 04-2004 | 04-2003 | 04-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,067 | -2,673 | -2,249 | -2,227 | -3,488 |
| Depreciation Amortization | 263 | 266 | 241 | 137 | 110 |
| Accounts receivable | 2 | 41 | -46 | 17 | -6 |
| Other Working Capital | -40 | 62 | 233 | -42 | -69 |
| Other Operating Activity | 1,693 | 312 | 48 | 22 | 1,555 |
| Operating Cash Flow | $-2,148 | $-1,992 | $-1,774 | $-2,094 | $-1,898 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -22 | -70 | -80 | -38 | -377 |
| Purchase Sale Intangibles | -34 | -37 | -25 | -27 | N/A |
| Other Investing Activity | -34 | -37 | -25 | -27 | 0 |
| Investing Cash Flow | $-56 | $-107 | $-105 | $-65 | $-377 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,294 | N/A | N/A | N/A | 190 |
| Common Stock Issued | 322 | 2,385 | 2,002 | 0 | 537 |
| Other Financing Activity | 0 | 0 | 0 | -106 | -262 |
| Financing Cash Flow | $1,616 | $2,385 | $2,002 | $-105 | $466 |
| Beginning Cash Position | 589 | 302 | 178 | 2,442 | 4,251 |
| End Cash Position | 0 | 589 | 302 | 178 | 2,442 |
| Net Cash Flow | $-588 | $287 | $124 | $-2,264 | $-1,809 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,148 | -1,992 | -1,774 | -2,094 | -1,898 |
| Capital Expenditure | -22 | -70 | -80 | -38 | -377 |
| Free Cash Flow | -2,170 | -2,062 | -1,854 | -2,132 | -2,274 |